Article

Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS- CoV-2 infection – a single-centre, retrospective, cohort study

2023-08-02

Abstract excerpt

<h4>Purpose: </h4> Despite 3.5 years of the SARS-CoV-2 pandemic we still lack effective drugs against COVID-19. The first and most used one, remdesivir, still has not been clearly proven to be effective in the treatment of adults. Its effectiveness in children is even less known. Therefore, this retrospective study aimed to evaluate the safety and efficacy of remdesivir in paediatric patients with COVID-19 hospita...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c67a5573-30c8-5935-b399-c38d6e29dff8
DOI: 10.21203/rs.3.rs-3209595/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS- CoV-2 infection – a single-centre, retrospective, cohort studyDOI 10.21203/rs.3.rs-3209595/v1Read

Use of Remdesivir in children with COVID-19: report of an Italian multicenter studySemantic proximity Read

Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results from an Italian Multicenter StudySemantic proximity Read

Clinical evidence of the effectiveness of remdesivir in COVID-19 during periods dominated by Delta and Omicron SARS-CoV-2 variants.Semantic proximity Read

Virologic features of SARS-CoV-2 infection in childrenSemantic proximity Read

Infection Control and Management of COVID-19: Challenges for Paediatric Tertiary Care HospitalsSemantic proximity Read

Determinants of Severity due to Covid-19 Among Young AdultsSemantic proximity Read

Epidemiological Characterization of SARS-CoV-2 Variants in Children Over the Four COVID-19 Waves and Correlation with Clinical PresentationSemantic proximity Read

The use of antiviral drugs in children.Semantic proximity Read

CLINICAL, EPIDEMIOLOGICAL AND VACCINATION CHARACTERISTICS IN CHILDREN AND ADOLESCENTS OF SEVERE ACUTE RESPIRATORY SYNDROME DUE TO COVID-19 IN BRAZIL (2020 TO 2024)Semantic proximity Read

Monoclonal antibody and antiviral therapy for treatment of mild-to-moderate COVID-19 in pediatric patientsSemantic proximity Read

Investigation of Sars-CoV-2 Infection in Children of families affected by COVID-19Semantic proximity Read

Immunogenicity and Safety Assessment of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine (Abdala) in Paediatric Ages 3 to 18 Years Old: A Double-Blinded, Multicentre, Randomised, Phase 1/2 Clinical Trial (ISMAELILLO Study)Semantic proximity Read